A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.
Phase: PHASE1 | Sponsor: Francisco A Moreno | Compound: Psilocybin
- Status
- recruiting
- Institution
- Francisco A Moreno
- Start date
- 2026-01-01
- End date
- 2029-01-01
- Registry ID
- NCT07347405
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.